Linked Life Data

18266660

Source:http://linkedlifedata.com/resource/pubmed/id/18266660

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-6-16
pubmed:abstractText
To test the hypothesis that stroke and systemic embolic events (SEE) in the stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) III and V trials are different between paroxysmal and persistent atrial fibrillation (AF).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1365-2796
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
264
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
50-61
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
pubmed:affiliation
University Department of Medicine, City Hospital, Birmingham, B18 7QH, United Kingdom. g.y.h.lip@bham.ac.uk
pubmed:publicationType
Journal Article, Randomized Controlled Trial